Biglycan is internalized via a chlorpromazine-sensitive route

• Autorzy: Gotte M , Feugaing D.D.S. , Kresse H.
• Języki publikacji: EN

Abstrakty

EN

The small leucine-rich proteoglycan biglycan (BGN) is abundantly expressed in mesenchymal tissues. Its expression level is related to the phenotypic differentiation of cells. A dysregulation in BGN expression occurs under several pathological conditions, including glomerulonephritis, mesothelioma, pancreatic cancer and a mouse model of osteoporosis. Since the extracellular concentration of BGN is regulated both by secretion and endocytosis, we performed mechanistic studies on BGN endocytosis in human skin fibroblasts in vitro, using inhibitors of different endocytic routes. Chlorpromazine, an inhibitor of the clathrin-coated pit-pathway reduced endocytosis of BGN in human skin fibroblasts by 40%, and decreased degradation of BGN by 66%. Filipin, an inhibitor of the caveolae pathway, and Tyrphostin AG 1478, a specific inhibitor of EGF-receptor phosphorylation that partially inhibits endocytosis of the structurally related proteoglycan decorin, had no influence on BGN internalization and degradation. Our data indicates that the classical clathrin-mediated endocytic pathway is a major route for the internalization of BGN. Based on the differential susceptibility to pharmacological inhibition, it appears that BGN endocytosis seems to be at least in part mechanistically different from decorin uptake.

Słowa kluczowe

EN

mesenchymal tissue; leucine-rich proteoglycan biglycan; proteoglycan; endocytosis; dermatan sulphate

• Wydawca: -
• Czasopismo: Cellular and Molecular Biology Letters
• Rocznik: 2004
• Tom: 09
• Numer: 3
• Opis fizyczny: p.475-481,fig.,ref.

Twórcy

autor

Gotte M

• Munster University Hospital, Domagkstr.11, D-48149 Munster, Germany

autor

Feugaing D.D.S.

autor

Kresse H.

Bibliografia

• 1. Fisher, L.W. Biglycan (BGN). In: Guidebook to the Extracellular Matrix, Anchor and Adhesion Proteins (Kreis, T. and Vale, R. Eds) 2nd edition, New York: Sambrook & Tooze at Oxford University Press, 1999, 365-368.
• 2. Young, M.F., Bi, Y., Ameye, L. and Chen, X.D. Biglycan knockout mice: new models for musculoskeletal diseases. Glycoconj. J. 19 (2002) 257-262.
• 3. Gulyas, M., Dobra, K. and Hjerpe, A. Expression of genes coding for proteoglycans and Wilms' tumour susceptibility gene 1 (WT1) by variously differentiated benign human mesothelial cells. Differentiation 65 (1999) 89-96.
• 4. Nielsen, K.L., Allen, M.R., Bloomfield, S.A., Andersen, T.L., Chen, X.D., Poulsen, H.S., Young, M.F. and Heegaard, A.M. Biglycan deficiency interferes with ovariectomy-induced bone loss. J. Bone Miner. Res. 18 (2003) 2152-2158.
• 5. Weber, C.K., Sommer, G., Michl, P., Fensterer, H., Weimer, M., Gansauge, F., Leder, G., Adler, G. and Gress, T.M. Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines. Gastroenterology 121 (2001) 657-667.
• 6. Chen, W.B., Lenshow, W., Tiede, K., Fischer, J.W., Kalthoff, H. and Ungefroren, H. Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells. J. Biol. Chem. 277 (2002) 36118-36128.
• 7. Gulyas, M. and Hjerpe, A. Proteoglycans and WT1 as markers for distinguishing adenocarcinoma, epithelioid mesothelioma, and benign mesothelium. J. Pathol. 199 (2003) 479-487.
• 8. Schaefer, L., Hausser, H., Altenburger, M., Ugorcakova, J., August, C., Fisher, L.W., Schaefer, R.M. and Kresse, H. Decorin, biglycan and their endocytosis receptor in rat renal cortex. Kidney Int. 54 (1998) 1529-1541.
• 9. Hausser, H., Ober, B., Quentin-Hoffmann, E., Schmidt, B. and Kresse, H. Endocytosis of different members of the small chondroitin/dermatan sulfate proteoglycan family. J. Biol. Chem. 267 (1992) 11559-11564.
• 10. Götte, M., Kresse, H. and Hausser, H. Endocytosis of decorin by bovine aortic endothelial cells. Eur. J. Cell Biol. 66 (1995) 226-233.
• 11. Caron de Fromentel, C., Nardeux, P.C., Soussi, T., Lavialle, C., Estrade, S., Carloni, G., Chandrasekaran, K. and Cassingena, R. Epithelial HBL-100 cell line derived from milk of an apparently healthy woman harbours SV40 genetic information. Exp. Cell Res. 160 (1985) 83-94.
• 12. Vanhorick, M. and Moens, W. Carcinogen-mediated induction of SV40 DNA amplification is enhanced by acrylamide in Chinese hamster CO60 cells. Carcinogenesis 4 (1983) 1459-1463.
• 13. Sofeu Feugaing, D.D., Götte, M., De la Motte, C., Drazba, J., Kresse, H. Involvement of different uptake routes in decorin endocytosis. Mol. Biol. Cell 13 (2002) S1919.
• 14. Wang, L.H., Rothberg, K.G. and Anderson, R.G. Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J. Cell Biol. 123 (1993) 1107-1117.
• 15. Schnitzer, J.E., Oh, P., Pinney, E. and Allard, J. Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J. Cell Biol. 127 (1994) 1217-1232.